Maarten K. Nijen Twilhaar

Author

Utrecht University

Also Known As

M.K. Nijen Twilhaar, Maarten K Nijen Twilhaar, Maarten K. Nijen Twilhaar

Publications

251

Citations

H-Index

Concepts

All Affiliations

Utrecht University University of Twente Vrije Universiteit Amsterdam National University of Singapore Amsterdam University Medical Centers

About

Maarten K. Nijen Twilhaar is an author at Utrecht University.

Maarten K. Nijen Twilhaar

Publications

227

Citations

H-Index

Page 1

	Year	Citations
CD169 Defines Activated CD14+ Monocytes With Enhanced CD8+ T Cell Activation Capacity Alsya J. Affandi, Katarzyna Olesek, Joanna Grabowska, Frontiers in Immunology	2021	59
Technical approaches to reduce interference of Fetal calf serum derived RNA in the analysis of extracellular vesicle RNA from cultured cells Tom A. P. Driedonks, Maarten K. Nijen Twilhaar, Esther N. M. Nolte‐‘t Hoen Journal of Extracellular Vesicles	2018	39
Liposome induction of CD8+ T cell responses depends on CD169+ macrophages and Batf3-dependent dendritic cells and is enhanced by GM3 inclusion Joanna Grabowska, Alsya J. Affandi, Dieke van Dinther, Journal of Controlled Release	2021	30
Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1 Joanna Grabowska, Dorian A. Stolk, Maarten K. Nijen Twilhaar, Vaccines	2021	27
Optimization of Liposomes for Antigen Targeting to Splenic CD169+ Macrophages Maarten K. Nijen Twilhaar, Lucas Czentner, Joanna Grabowska, Pharmaceutics	2020	25
Myeloid effector cells in cancer Pieter J. Schol, Marit J van Elsas, Jim Middelburg, Cancer Cell	2024	19
Incorporation of Toll-Like Receptor Ligands and Inflammasome Stimuli in GM3 Liposomes to Induce Dendritic Cell Maturation and T Cell Responses Maarten K. Nijen Twilhaar, Lucas Czentner, Rianne G. Bouma, Frontiers in Immunology	2022	17
Nanobody-liposomes as novel cancer vaccine platform to efficiently stimulate T cell immunity Rianne G. Bouma, Maarten K. Nijen Twilhaar, Hendrik J. Brink, International Journal of Pharmaceutics	2024	11

Page 1